Lexicon Pharmaceuticals, Inc. (LXRX) Social Stream
LEXICON PHARMACEUTICALS INC (LXRX) Price Targets From Analysts
Use the tables below to see what analysts covering LEXICON PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 1 | $6 | $6 | $6 | $1.2 | 400% |
| 2022-06-13 | 1 | $5 | $5 | $5 | $1.2 | 316.67% |
| 2022-07-01 | 2 | $20 | $5 | $12.5 | $1.2 | 941.67% |
| 2023-03-02 | 3 | $20 | $10 | $15 | $1.2 | 1150% |
| 2023-05-02 | 4 | $20 | $3 | $11 | $1.2 | 816.67% |
| 2023-08-03 | 4 | $10 | $3 | $7 | $1.2 | 483.33% |
| 2023-08-05 | 4 | $10 | $2.3 | $5.766 | $1.2 | 380.5% |
| 2023-10-10 | 4 | $10 | $1.65 | $5.55 | $1.2 | 362.5% |
| 2023-11-08 | 4 | $10 | $1.45 | $5.483 | $1.2 | 356.92% |
The Trend in the Analyst Price Target
Over the past 43 months, LXRX's average price target has gone up $0.78.
Over the past 36 weeks, LXRX's average upside potential has been 330.04%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-02 | 2 | 20 | 10.00 | 15.000 | 2.18 | 588.07% |
| 2023-05-02 | 4 | 20 | 3.00 | 11.000 | 2.38 | 362.18% |
| 2023-05-02 | 3 | 20 | 3.00 | 11.000 | 2.38 | 362.18% |
| 2023-08-05 | 4 | 10 | 2.30 | 5.766 | 1.87 | 208.34% |
| 2023-11-08 | 4 | 10 | 1.45 | 5.483 | 1.14 | 380.96% |
LXRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
LXRX's average broker recommendation rating improved by 0 over the prior 123 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, LEXICON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1410.62% of them.
- LXRX has a lower variance in analysts' estimates than -800.16% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, LEXICON PHARMACEUTICALS INC's number of analysts covering the stock is greater than 108.18% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, LEXICON PHARMACEUTICALS INC's average analyst price target is higher than 254.54% of them.
Stocks similar to LEXICON PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CBAY, RMTI, and RIGL.
View All Top Stocks by Price Target
Is LXRX a Buy, Hold or Sell? See the POWR Ratings now!